Nitric oxide: An antioxidant and neuroprotector

Annals of the New York Academy of Sciences

Volumn 962, Issue , 2002, Pages 389-401

  Mohanakumar, Kochupurackal P ^a   Thomas, Bobby ^a   Sharma, Sudarshana M ^a   Muralikrishnan, Dhanasekharan ^a   Chowdhury, Rukhsana ^a   Chiueh, Chuang C ^b  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Ferrous citrate; Free radical scavenger; Hydroxyl radicals; Inducible nitric oxide synthase mRNA; MPTP; Nitric oxide donors; Nitroglycerine

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 7 NITROINDAZOLE; BROMOCRIPTINE; CALCIUM CHANNEL BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FERROUS CITRATE FE 59; GLYCERYL TRINITRATE; HYDROXYL RADICAL; IRON COMPLEX; MELATONIN; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SALICYLIC ACID; SCAVENGER; SELEGILINE;

ANIMAL MODEL; ANTIOXIDANT ACTIVITY; COMPLEX FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOSE RESPONSE; GENE EXPRESSION; LIPID PEROXIDATION; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; TRANSGENIC ANIMAL;

ANIMALIA; LETHRINIDAE;

EID: 0036274895     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04083.x     Document Type: Conference Paper

References (39)

1. Hydroxyl radicals and nitric oxide in neurotoxicity and neuroprotection
2. Nitric oxide: A neural messenger
3. Nitric oxide mediates glutamate toxicity in primary cortical cultures
4. Parkinsonism-inducing neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine: Uptake of the metabolite N-methyl-4-phenylpyridinium by dopamine neurons explains selective toxicity
5. The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters
6. Implication of poly (ADP-ribose) polymerase (PARP) in neurodegeneration and brain energy metabolism. Decreases in mouse brain NAD+ and ATP caused by MPTP are prevented by the PARP inhibitor benzamide
7. Mitochondrial dysfunction in Parkinson's disease
8. The neurobiology of NO and OH
9. Neurochemical mechanisms underlying neuroprotective actions of bromocriptine, salicylate, D- and L-deprenyl in neurodegeneration caused by MPTP
10. +: Implications for neurodegeneration
11. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism
12. In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
13. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons
14. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity
15. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
16. Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity
17. Ferrous-citrate complex and nigral degeneration: Evidence for free-radical formation and lipid peroxidation
18. A fluorometric assay for the measurement of nitrite in biological samples
19. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
20. Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice
21. Oxidative stress and genetics in the pathogenesis of Parkinson's disease
22. Causes of neuronal death in Parkinson's disease
23. Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation
24. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2
25. L-Glutamate, L-arginine, and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients
26. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice
27. 7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced ATP loss in the mouse striatum
28. Role of endogenous nitric0 oxide and peroxynitrite formation in the survival and death of motor neurons in culture
29. Neuroprotective properties of nitric oxide
30. Apparent role of hydroxyl radicals in oxidative brain injury induced by sodiumnitroprusside
31. S-nitrosothiols and nitric oxide, but not sodium nitroprusside, protect nigrostriatal dopamine neurons against iron induced oxidative stress in vivo
32. Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production
33. Nitric oxide donors protect cultured rat astrocytes from 1-methyl-4-phenylpyridinium-induced toxicity
34. Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity
35. S-methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity
36. Reduction of MPP(+)-induced hydroxyl radical formation and nigrostriatal MPTP toxicity by inhibiting nitric oxide synthase
37. Astrocyte-derived nitric oxide causes both reversible and irreversible damage to the neuronal mitochondrial respiratory chain
38. Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo
39. Methamphetamine- and 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice